Ratiopharm is a prominent brand known as the first generics company in Europe. Acquired by Teva Pharmaceuticals in 2010, the company offers a wide array of OTC and generic prescription medicines in European markets including Germany, Austria, Spain, and Finland.
With a foundation dating back to 1973, Ratiopharm is deeply entrenched in the manufacturing and pharmaceutical industries. As part of Teva, the company leverages access to innovative networks and high-quality, internally produced active ingredients.
Ratiopharm's core focus lies in ensuring access to medicines and the supply of essential pharmaceuticals to millions of individuals. Their commitment to delivering high-quality generics tailored to the needs of patients is underscored by their belief that quality can be availed at fair prices, making a sustainable contribution to the efficiency of the healthcare system.